Haemodynamic effects of high or low doses of furosemide in acute myocardial infarction. 1988

F F Larsen
Department of Medicine, Karolinska Hospital, Stockholm, Sweden.

The haemodynamic effects of high or low doses of furosemide used to prevent overt left heart failure (LHF) in acute myocardial infarction (AMI) were studied. Fifteen consecutive AMI patients without overt LHF and with a cardiac index (CI) of 2.6 +/- 0.5 l min-1 m-2, a right atrial mean pressure (RAMP) of 7 +/- 3 mmHg and a pulmonary arterial diastolic pressure (PADP) of 14 +/- 4 mmHg were investigated during 24 h. A high dose group (HDG) received 40 mg furosemide t.i.d. and a low dose group (LDG) 20 mg once daily. Following the first 40 mg of furosemide (HDG), the stroke volume index (SVI), CI, RAMP and PADP decreased. The heart rate and systemic vascular resistance index (SVRI) increased. Following the first 20 mg of furosemide (LDG), the only significant change was a decrease in PADP. After 24 h, the heart rate in the HDG was further increased; the SVI, RAMP and PADP were further reduced, whereas CI was similar to that before. In the LDG, the heart rate, SVI and CI remained unchanged. All pressures tended to decline and the SVRI was lower than in the HDG. Thus, repeated injections of 40 mg of furosemide induced a sustained preload reduction in AMI patients without overt LHF, but this was associated with potentially disadvantageous haemodynamic findings.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008297 Male Males
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D011187 Posture The position or physical attitude of the body. Postures
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002302 Cardiac Output The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat). Cardiac Outputs,Output, Cardiac,Outputs, Cardiac
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D005665 Furosemide A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. Frusemide,Fursemide,Errolon,Frusemid,Furanthril,Furantral,Furosemide Monohydrochloride,Furosemide Monosodium Salt,Fusid,Lasix
Copied contents to your clipboard!